Global Breast Localization System Market Size study, By Device Type (Wire Guided, Radioisotope, Radioactive-Seed Localization (RSL), Radio Guided Occult-Lesion Localization (ROLL), Magnetic Tracer}, By Application (Breast Biopsy, Lumpectomy), By End User

Global Breast Localization System Market Size study, By Device Type (Wire Guided, Radioisotope, Radioactive-Seed Localization (RSL), Radio Guided Occult-Lesion Localization (ROLL), Magnetic Tracer}, By Application (Breast Biopsy, Lumpectomy), By End User (Hospital, Ambulatory Surgical Center, Diagnostic Center, Ambulatory Care Center, Specialty Clinic, Others), and Regional Forecasts 2022-2028

Global Breast Localization System Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Breast localization systems refers to medical devices which are used to examine abnormalities in breast. Breast localization systems. Wire-guided localization (WGL) is widely used localization method, Wire free localization is also gaining popularity in recent times. Needle localization is done before performing breast surgery to locate abnormality in breast. Increasing prevalence of breast cancer and rising consumer spending on enhancing body aesthetics coupled with recent regulatory approvals are key drivers for growth of Breast localization systems Market. For instance, According to World Health Organization’s estimates - In 2020 around 2.3 million women were diagnosed with breast cancer and breast cancer alone accounted for 685, 000 deaths globally. Further, at the end of 2020, there were 7.8 million women were diagnosed with breast cancer in the past 5 years. Moreover, in April 2022, Merit Medical Systems, Inc. received FDA clearance for its SCOUT Bx breast localization System. This new system is said to be which company’s first wire-free breast localization solution. Further, in April 2021, FDA provided clearance for MOLLI Surgical Inc.’s Molli, a wire-free localization technology. This new device is intended for detection of small, nonpalpable tumors along with a detection wand and visualization tablet. Also, with increasing demand for the early detection of breast cancer coupled with rising healthcare spending from emerging economies, the Market would witness impressive growth opportunities in the forecasted period. However, high cost of treatment and localization devices and dearth of skilled healthcare professionals hinder the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Breast Localization System Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rising adoption of cosmetics surgical procedures and presence of leading manufacturer in the region. Whereas Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as the rising incidence of breast cancer and growing healthcare infrastructure in the region, would create lucrative growth prospects for the Breast Localization System Market across the Asia Pacific region.

Major market players included in this report are:
Ranfac Corporation
C.R. Bard Inc.
Invivo Corporation
SOMATEX Medical Technologies GmbH
SurgicEye GmbH
Cianna Medical Inc.
Cook Medical Inc.
GE Healthcare Inc.
Argon Medical Devices, Inc.
Intra-Medical Imaging LLC


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Device Type
Wire Guided, Radioisotope
Radioactive-Seed Localization (RSL)
Radio Guided Occult-Lesion Localization (ROLL)
Magnetic Tracer
By Application
Breast Biopsy
Lumpectomy
By End User
Hospital
Ambulatory Surgical Center
Diagnostic Center
Ambulatory Care Center
Specialty Clinic
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Breast Localization System Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Ranfac Corporation
C.R. Bard Inc.
Invivo Corporation
SOMATEX Medical Technologies GmbH
SurgicEye GmbH
Cianna Medical Inc.
Cook Medical Inc.
GE Healthcare Inc.
Argon Medical Devices, Inc.
Intra-Medical Imaging LLC

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.